Truist upgraded Sangamo (SGMO) to Buy from Hold with a $7 price target The firm says that with the company’s expenses streamlined, the shares could see potential upside in the next 12-18 months with more business development adding non-dilutive funding. Over the past year, Sangamo has right-sized its cost basis, refocused its research and development and is advancing its pipeline to enhance the company’s financial positioning, the analyst tells investors in a research note.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMO: